375 related articles for article (PubMed ID: 27389475)
21. Treatment outcome in patients undergoing surgery for carcinoma larynx and hypopharynx: a follow-up study.
Varghese BT; Sebastian P; Mathew A
Acta Otolaryngol; 2009 Dec; 129(12):1480-5. PubMed ID: 19922101
[TBL] [Abstract][Full Text] [Related]
22. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients.
Altundag O; Gullu I; Altundag K; Yalcin S; Ozyar E; Cengiz M; Akyol F; Yucel T; Hosal S; Sozeri B
Head Neck; 2005 Jan; 27(1):15-21. PubMed ID: 15515158
[TBL] [Abstract][Full Text] [Related]
23. Concurrent chemoradiotherapy improves survival in patients with hypopharyngeal cancer.
Paximadis P; Yoo G; Lin HS; Jacobs J; Sukari A; Dyson G; Christensen M; Kim H
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1515-21. PubMed ID: 21658855
[TBL] [Abstract][Full Text] [Related]
24. Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer. A long-term follow-up report.
Karp DD; Vaughan CW; Carter R; Willett B; Heeren T; Calarese P; Zeitels S; Strong MS; Hong WK
Am J Clin Oncol; 1991 Aug; 14(4):273-9. PubMed ID: 1713738
[TBL] [Abstract][Full Text] [Related]
25. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary.
Lefebvre JL; Ang KK;
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1293-303. PubMed ID: 19306746
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
[TBL] [Abstract][Full Text] [Related]
27. [Comparative analysis of clinical efficacies between induction chemotherapy and surgery combined with radiotherapy or concurrent chemoradiotherapy in advanced hypopharyngeal carcinoma].
Li ZD; Lu T
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Dec; 53(12):918-924. PubMed ID: 30585004
[No Abstract] [Full Text] [Related]
28. Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation.
Janoray G; Pointreau Y; Garaud P; Chapet S; Alfonsi M; Sire C; Jadaud E; Calais G
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26681800
[TBL] [Abstract][Full Text] [Related]
29. Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal Carcinoma.
Luo X; Huang X; Liu S; Wang X; Luo J; Xiao J; Wang K; Qu Y; Chen X; Zhang Y; Wang J; Zhang J; Xu G; Gao L; Wu R; Yi J
JAMA Netw Open; 2022 Feb; 5(2):e220165. PubMed ID: 35191967
[TBL] [Abstract][Full Text] [Related]
30. Clinical Predictors of Laryngeal Preservation Rate in Stage III-IV Laryngeal Cancer and Hypopharyngeal Cancer Patients Treated with Organ Preservation.
Tangsriwong K; Jitreetat T
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2051-2057. PubMed ID: 31350965
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the therapeutic effects of total laryngectomy and a larynx-preservation approach in patients with T4a laryngeal cancer and thyroid cartilage invasion: A multicenter retrospective review.
Choi YS; Park SG; Song EK; Cho SH; Park MR; Park KU; Lee KH; Song IC; Lee HJ; Jo DY; Kim S; Yun HJ;
Head Neck; 2016 Aug; 38(8):1271-7. PubMed ID: 27043228
[TBL] [Abstract][Full Text] [Related]
32. [Treatment and prognosis of 264 patients with hypopharyngeal carcinoma].
Xu W; Lyu ZH; Sa N; Ma JK; Tian JJ; Feng SH; Cui P; Cao HY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):346-351. PubMed ID: 29764015
[No Abstract] [Full Text] [Related]
33. Oncological and functional outcomes in T3 and T4 laryngeal cancer patients: choice for larynx preservation or total laryngectomy based on expected laryngeal function.
Nobacht A; Meijer TWH; Oosting SF; van der Vegt B; Wedman J; Halmos GB; Plaat BEC
J Laryngol Otol; 2024 Jun; 138(6):672-678. PubMed ID: 38235588
[TBL] [Abstract][Full Text] [Related]
34. Laryngeal preservation in ENT oncology. Retrospective series of 246 patients managed in the Caen University Hospital and François Baclesse Cancer Care Center between 1998 and 2008.
Cuny F; Meunier A; Heutte N; Rame JP; De Raucourt D; Babin E; Blanchard D
Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Jun; 132(3):129-34. PubMed ID: 25838235
[TBL] [Abstract][Full Text] [Related]
35. Salvage radiotherapy for recurrent hypopharyngeal and laryngeal squamous cell carcinoma (SCC) after first-line treatment with surgery alone: a 10-year single-centre experience.
Akbaba S; Held T; Lang K; Hoerner-Rieber J; Zaoui K; Forster T; Rieken S; Plinkert P; Debus J; Adeberg S
Radiat Oncol; 2019 Feb; 14(1):34. PubMed ID: 30782197
[TBL] [Abstract][Full Text] [Related]
36. Selection of therapeutic treatment with alternating chemoradiotherapy for larynx preservation in laryngeal carcinoma patients.
Ijichi K; Hanai N; Kawakita D; Ozawa T; Suzuki H; Hirakawa H; Kodaira T; Murakami S; Hasegawa Y
Jpn J Clin Oncol; 2014 Nov; 44(11):1063-9. PubMed ID: 25187666
[TBL] [Abstract][Full Text] [Related]
37. Oncologic and functional outcomes in advanced laryngeal and hypopharyngeal cancer treated with concurrent chemoradiation versus primary surgery followed by adjuvant treatment.
Jantharapattana K
J Med Assoc Thai; 2013 Sep; 96(9):1164-8. PubMed ID: 24163992
[TBL] [Abstract][Full Text] [Related]
38. Organ preservation with concurrent chemoradiation for advanced laryngeal cancer: are we succeeding?
Lambert L; Fortin B; Soulières D; Guertin L; Coulombe G; Charpentier D; Tabet JC; Bélair M; Khaouam N; Nguyen-Tan PF
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):398-402. PubMed ID: 19394155
[TBL] [Abstract][Full Text] [Related]
39. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
[TBL] [Abstract][Full Text] [Related]
40. [Organ preservation in advanced laryngeal/hypopharyngeal carcinoma: lessons from the DeLOS-II trial].
Dietz A; Wichmann G; Kuhnt T; Wiegand S
HNO; 2020 Sep; 68(9):648-656. PubMed ID: 32468135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
